⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GNPX News
Genprex, Inc. Common Stock
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
prnewswire.com
GNPX
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
prnewswire.com
GNPX
Cradle AI-powered protein engineering platform serving six of top 25 pharma leaders
prnewswire.com
JNJ
ABBV
GOOG
META
UBER
GNPX
Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer
prnewswire.com
GNPX
Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials
prnewswire.com
GNPX
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
prnewswire.com
GNPX
Genprex Announces European Patent Office's Intent to Grant a Patent for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
prnewswire.com
GNPX
Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules
prnewswire.com
GNPX
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
prnewswire.com
GNPX
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics
prnewswire.com
GNPX